Open | - |
Close | - |
Volume / Avg. | 0 / 141.947K |
Day Range | - - - |
52 Wk Range | 0.891 - 2.330 |
Market Cap | $11.144M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 4.07% |
Days to Cover | 2.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.11 last updated March 18, 2024 at 7:08 PM EDT.
There are no upcoming dividends for Organovo Holdings.
Organovo Holdings’s Q3 earnings are confirmed for Thursday, February 8, 2024.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.